Company research
SiriusPoint Ltd
CIK 1576018Updated Sep 26, 2026
SecuritiesSPNT · NYSE · equitySSPFF · OTC · warrant
Historical securities (1)
TPRE · OTC · equity · closed Feb 26, 2021Name history
Third Point Reinsurance Ltd. · through Feb 26, 2021
SPNT price & chart
Loading TradingView…
NYSE:SPNT on TradingView ↗About the company
SiriusPoint is a global underwriter of insurance and reinsurance providing solutions to clients and brokers around the world. Bermuda-headquartered with offices in New York, London, Stockholm and other locations, we are listed on the New York Stock Exchange (SPNT). We have licenses to write Property & Casualty and Accident & Health insurance and reinsurance globally. Our offering and distribution capabilities are strengthened by a portfolio of strategic partnerships with Managing General Agents and Program Administrators within our Insurance & Services segment. With approximately $2.8 billion in total capital, SiriusPoint’s operating companies have a financial strength rating of A- (Excellent) from AM Best, S&P and Fitch, and A3 from Moody’s. For more information, please visit www.siriuspt.com.
In the news
SiriusPoint Reports Second Quarter 2026 Net Income of $69m, Return on Equity of 12.0% and Operating Return on Equity of 13.8% ↗
Recent filings
4 filing
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
4 filing
4 filing
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 12,569,600,000Source | 12,524,900,000Source | 12,871,500,000Source | 11,036,300,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 121,200,000Source | 140,800,000Source | 152,700,000Source | 163,800,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 731,200,000Source | 682,000,000Source | 969,200,000Source | 705,300,000Source |
| Operating Lease, Right-of-Use AssetUSD | 20,700,000Source | 22,800,000Source | 25,600,000Source | 25,900,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 10,098,700,000Source | 10,586,100,000Source | 10,340,900,000Source | 8,953,700,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 11,700,000Source | 11,600,000Source | 16,800,000Source | 16,200,000Source |
| Additional Paid in CapitalUSD | 967,700,000Source | 945,000,000Source | 1,693,000,000Source | 1,641,300,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,228,500,000Source | 784,900,000Source | 601,000,000Source | 262,200,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 61,900,000Source | -4,100,000Source | 3,100,000Source | -45,000,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,469,800,000Source | 1,937,400,000Source | 2,513,900,000Source | 2,074,700,000Source |
| Liabilities and EquityUSD | 12,569,600,000Source | 12,524,900,000Source | 12,871,500,000Source | 11,036,300,000Source |
| Deferred Income Tax Liabilities, NetUSD | 73,000,000Source | 76,200,000Source | 68,700,000Source | 59,800,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 1,100,000Source | 1,400,000Source | 16,700,000Source | 7,900,000Source |
| Additional Financial Items | ||||
| Long-term DebtUSD | 688,600,000Source | 639,100,000Source | 786,200,000Source | 778,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 460,100,000Source | 202,400,000Source | 363,700,000Source | -386,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 35,900,000Source | 20,700,000Source | 21,400,000Source | 30,500,000Source |
| Deferred Income Tax Expense (Benefit)USD | 33,000,000Source | 10,900,000Source | -77,300,000Source | -39,200,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 102,400,000Source | 74,700,000Source | 581,300,000Source | 293,300,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 424,200,000Source | 343,600,000Source | -332,200,000Source | -1,304,300,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 6,300,000Source | 9,800,000Source | 11,500,000Source | 7,100,000Source |
| Payments for Repurchase of Common StockUSD | 490,800,000Source | 299,700,000Source | 0Source | 5,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -518,800,000Source | -625,000,000Source | -61,500,000Source | -23,700,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 0Source | 0Source | 0Source | 0Source |
| Repayments of Long-term DebtUSD | 0Source | 517,900,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 7,800,000Source | -206,700,000Source | 187,600,000Source | -1,034,700,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 902,400,000Source | 894,600,000Source | 1,101,300,000Source | 913,700,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 78,000,000Source | 66,400,000Source | 46,100,000Source | 39,200,000Source |
| Income Taxes Paid, NetUSD | 81,700,000Source | 50,600,000Source | 49,600,000Source | -2,200,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 35,900,000Source | 18,300,000Source | 21,400,000Source | 26,800,000Source |
| Amortization of Intangible AssetsUSD | 10,900,000Source | 11,900,000Source | 11,100,000Source | 8,100,000Source |
| Debt Securities, Available-for-sale, Realized Gain (Loss)USD | 3,800,000Source | -9,600,000Source | -10,000,000Source | 2,700,000Source |
| Debt Securities, Realized Gain (Loss)USD | 0Source | -800,000Source | — | — |
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, AmortizationUSD | 583,600,000Source | 516,900,000Source | 472,700,000Source | 461,900,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 0Source | -2,300,000Source |
| Equity Securities, FV-NI, Unrealized Gain (Loss)USD | — | — | -100,000Source | 1,800,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -25,200,000Source | 10,000,000Source | -34,900,000Source | 66,000,000Source |
| Gain (Loss) on InvestmentsUSD | -2,900,000Source | -88,700,000Source | -10,000,000Source | -225,500,000Source |
| Gain (Loss) on Disposition of BusinessUSD | — | — | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 81,200,000Source | 30,700,000Source | -45,000,000Source | -36,700,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 1,519,500,000Source | 1,368,500,000Source | 1,381,300,000Source | 1,588,400,000Source |
| Net Income (Loss) Attributable to ParentUSD | 459,600,000Source | 199,900,000Source | 354,800,000Source | -386,800,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 500,000Source | 2,500,000Source | 8,900,000Source | 800,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 443,300,000Source | 176,200,000Source | 314,500,000Source | -402,800,000Source |
| Payments to Acquire InvestmentsUSD | — | — | 4,966,100,000Source | 6,161,300,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | 0Source | 0Source |
| Proceeds from Noncontrolling InterestsUSD | — | — | 800,000Source | 800,000Source |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | -800,000Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 900,000Source | 18,400,000Source | 3,000,000Source | 0Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | -2,200,000Source | -600,000Source | -1,500,000Source | — |
| Realized Investment Gains (Losses)USD | -23,100,000Source | -23,300,000Source | -40,700,000Source | -76,100,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | -200,000Source | -1,200,000Source | 4,800,000Source | — |
| Unrealized Gain (Loss) on InvestmentsUSD | 20,200,000Source | -65,400,000Source | 30,700,000Source | -149,400,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 3,205,100,000Source | 2,603,800,000Source | 2,737,300,000Source | 2,105,600,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 541,300,000Source | 233,100,000Source | 318,700,000Source | -422,700,000Source |
| Income Tax Expense (Benefit)USD | 81,200,000Source | 30,700,000Source | -45,000,000Source | -36,700,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 500,000Source | 2,500,000Source | 8,900,000Source | 800,000Source |
| Net Income (Loss) Attributable to ParentUSD | 459,600,000Source | 199,900,000Source | 354,800,000Source | -386,800,000Source |
| Earnings Per Share, BasicUSD per share | 3.8Source | 1.06Source | 1.93Source | -2.51Source |
| Earnings Per Share, DilutedUSD per share | 3.64Source | 1.04Source | 1.85Source | -2.51Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 116,507,940Source | 166,537,394Source | 163,341,448Source | 160,228,588Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 121,648,050Source | 169,470,681Source | 169,607,348Source | 160,228,588Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 10,900,000Source | 11,900,000Source | 11,100,000Source | 8,100,000Source |
| Benefits, Losses and ExpensesUSD | 2,663,800,000Source | 2,370,700,000Source | 2,418,600,000Source | 2,528,300,000Source |
| Current Income Tax Expense (Benefit)USD | 48,200,000Source | 19,800,000Source | 32,300,000Source | 2,500,000Source |
| Debt Securities, Realized Gain (Loss)USD | 0Source | -800,000Source | — | — |
| Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, AmortizationUSD | 583,600,000Source | 516,900,000Source | 472,700,000Source | 461,900,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | — | — | 0Source | -2,300,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -25,200,000Source | 10,000,000Source | -34,900,000Source | 66,000,000Source |
| Gain (Loss) on InvestmentsUSD | -2,900,000Source | -88,700,000Source | -10,000,000Source | -225,500,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 25,100,000Source | 53,700,000Source | 21,500,000Source | -151,700,000Source |
| Interest ExpenseUSD | 79,700,000Source | 69,600,000Source | 64,100,000Source | 38,600,000Source |
| Interest Expense, DebtUSD | 47,900,000Source | 48,100,000Source | 45,400,000Source | 38,600,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 1,519,500,000Source | 1,368,500,000Source | 1,381,300,000Source | 1,588,400,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 443,300,000Source | 176,200,000Source | 314,500,000Source | -402,800,000Source |
| Net Investment IncomeUSD | 274,800,000Source | 303,600,000Source | 283,700,000Source | 113,300,000Source |
| Other Cost and Expense, OperatingUSD | 257,000,000Source | 232,100,000Source | 258,200,000Source | 312,800,000Source |
| Other IncomeUSD | 339,400,000Source | 184,200,000Source | 38,400,000Source | 110,200,000Source |
| Realized Investment Gains (Losses)USD | -23,100,000Source | -23,300,000Source | -40,700,000Source | -76,100,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | 300,000Source | 7,700,000Source | 24,300,000Source | 0Source |
Filing attachments
d100799dex991.htm · 8-K · 2026-01-29
EX-99.1 2 d100799dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 SiriusPoint Announces Redemption of Series B Preference Shares HAMILTON, Bermuda, January 29, 2026 - SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, announced today that the Company will redeem all 8 million of its issued and outstanding 8.00% Resettable Fixed Rate Preference Shares, Series B (“Series B Preference Shares”) on February 26, 2026 (the “Redemption Date”). The red…
Read attachment ↗d68415dex991.htm · 8-K · 2025-10-06
EX-99.1 2 d68415dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 PRESS RELEASE SiriusPoint Announces Sale of Arcadian MGA for $139m and with Long Term Capacity Deal Until 2031 HAMILTON, Bermuda, October 6, 2025 - SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced its agreement to sell its 49% equity stake in managing general agent, Arcadian Risk Capital (“Arcadian”) to Lee Equity Partners for total consideration of $139 million, inclusiv…
Read attachment ↗d14461dex991.htm · 8-K · 2025-09-29
EX-99.1 2 d14461dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 PRESS RELEASE SiriusPoint Announces Sale of ArmadaCare MGA for $250m with Long Term Capacity Deal Until 2030 Hamilton, Bermuda (September 29, 2025) - SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced its agreement to sell wholly owned supplemental health insurance program manager, ArmadaCare (“Armada”) to Ambac Financial Group Inc. (“Ambac”) for $250 million. SiriusPoint wil…
Read attachment ↗d266090dex991.htm · 8-K · 2025-09-03
EX-99.1 2 d266090dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 PRESS RELEASE SiriusPoint appoints Martin Hudson to Board of Directors HAMILTON, Bermuda, September 3, 2025 - SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Martin Hudson as Board Director, effective September 1, 2025. Mr. Hudson has more than 40 years of international (re)insurance leadership experience, spanning underwriting, risk m…
Read attachment ↗d933901dex991.htm · 8-K · 2025-02-27
EX-99.1 4 d933901dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 SiriusPoint Announces Closing of CM Bermuda Transaction & Completion of Registered Secondary Offering of 4,106,631 Common Shares by Entities Associated with Daniel S. Loeb HAMILTON, Bermuda (February 27, 2025) - SiriusPoint Ltd. (“SiriusPoint”) (NYSE: SPNT), a global specialty insurer and reinsurer, announced today the closing of its previously announced transaction to repurchase all SiriusPoint common shares and warrants held by CM…
Read attachment ↗d926668dex991.htm · 8-K · 2025-01-29
EX-99.1 2 d926668dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 SiriusPoint Announces Dividend on Series B Preference Shares HAMILTON, Bermuda January 29, 2025 - SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced that the Audit Committee of the Board of Directors of SiriusPoint Ltd. has approved a quarterly cash dividend of $0.50 per share on its 8.00% Resettable Fixed Rate Preference Shares, Series B, $0.10 par value, $2…
Read attachment ↗